期刊文献+

EphA 2和KAI 1蛋白在膀胱移行细胞癌组织中的表达及其意义 被引量:2

Expressions of EphA 2 and KAI 1 in human bladder transitional cell carcinoma and its significance
下载PDF
导出
摘要 目的:探讨EphA 2蛋白和KAI 1蛋白的表达与膀胱移行细胞癌发生及浸润转移的关系以及两者表达的相关性。方法:采用免疫组织化学SP法,检测EphA 2蛋白和KAI 1蛋白在88例膀胱移行细胞癌组织及76例相应癌旁正常膀胱黏膜中的表达。结果:EphA 2蛋白在癌组织中的表达明显高于其癌旁正常黏膜(P<0.01);随着膀胱癌病理分级的升高,EphA 2蛋白的表达逐渐增加(P<0.05);在浸润性膀胱癌中的表达明显高于表浅性膀胱癌患者(P<0.05);有淋巴结转移组的表达明显高于无淋巴结转移组(P<0.05)。KAI 1蛋白在癌组织中的表达明显低于癌旁正常膀胱黏膜(P<0.01);随着膀胱癌病理分级的升高,KAI1蛋白的表达逐渐减少(P<0.01);KAI 1在浸润性膀胱癌中的表达明显低于表浅性膀胱癌患者(P<0.05);有淋巴结转移组的表达明显低于无淋巴结转移组(P<0.05)。EphA 2蛋白和KAI 1蛋白的表达在有淋巴结转移的患者中呈显著负相关(P<0.05)。结论:EphA 2蛋白的高表达和KAI 1蛋白的低表达与膀胱移行细胞癌的发生及浸润转移有关。 Objective:To investigate the association of EphA 2 and KAI 1 protein expressions with the occurrence, invasion, and metastasis of bladder transitional cell carcinoma tissues (BTCC).Methods:The expressions of EphA 2 and KAI 1 proteins were determined by immunohistochemical SP method in 88 cases of BTCC tissues and 76 cases of pericancerous normal bladder tissues.Results:The expression of EphA 2 protein was significantly higher in BTCC tissues than in adjacent normal tissues (P〈0.01). The expression of EphA 2 protein was gradually increased with the elevation of pathological grades of BTCC. The positive rate of EphA 2 expression was significantly higher in deeply infiltrating BTCC than superficially infiltrating BTCC (P〈0.05). It was significantly higher in the group with lymph node metastasis than those without lymph node metastasis (P〈0.05). The expression of KAI 1 protein was significantly lower in BTCC tissues than in adjacent normal tissues (P〈0.01). The expression of KAI 1 was gradually decreased with the elevation of pathological grades of BTCC. The positive rate of KAI 1 expression was significantly lower in deeply infiltrating BTCC than in superficially infiltrating BTCC (P〈0.05). It was significantly lower in the BTCC with lymph node metastasis than those without lymph node metastasis (P〈0.05). A significantly negative correlation was observed between the expression of EphA 2 and that of KAI 1 in BTCC tissues with lymph node metastasis (P〈0.05). Conclusion:Overexpression of EphA 2 and weak expression of KAI 1 may be involved in the tumorigenesis, infiltration, and migration of BTCC.
出处 《肿瘤》 CAS CSCD 北大核心 2008年第2期142-145,共4页 Tumor
基金 宜昌市2006年医疗卫生科技计划项目(编号:A06403)
关键词 膀胱肿瘤 基因表达 基因 Epha 2 基因 KAI 1 Bladder neoplasms Gene expression Gene,EphA 2 Gene, KAI 1
  • 相关文献

参考文献13

  • 1WALKER-DANIELS J, COFFMAN K, AZIMI M,et al. Overexpression of the EphA 2 tyrosine kinase in prostate cancer[ J ]. Prostate, 1999,41 (4) :275-280.
  • 2ZELINSKI D P, ZANTEK N D, STEWART J C,et al. EphA 2 overexpression causes tumori genesis of mammary epithelial cells [ J ]. Cancer Res, 2001,61 (5) :2301-2306.
  • 3CARLES-KINCH K, KILPATRICK K E, STEWART J C, et al. Antibody targeting of the EphA 2 tyrosine kinase inhibits malignant cell behavior [ J ]. Cancer Res,2002,62 ( 10 ) :2840 -2847.
  • 4STRAUME O, AKSLEN L A. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor- 1 and ephrin-A 1/EphA 2 on melanoma progression[J]. Am J Pathol, 2002, 160(3) :1009-1019.
  • 5KINCH M S, MOORE M B, HARPOLE D H, et al. Predictive value of the EphA 2 tyrosine kinase in lung cancer recurrence and survival[ J ]. Clin Cancer Res, 2003,9 (2) :613 -618.
  • 6MIYAZAKI T, KATO H, FUKUCHI M, et al. EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma[J], lnt J Cancer, 2003, 103 (5) :657-663.
  • 7DONG JT,LAMB PW, RINKER-SCHAEFER CW, et al. KAI1 ,a metastasis suppressor gene for prostate cancer on human chromosome 11P11.2[J]. Science,1995, 268(5213) :884-886.
  • 8ADACHI M,TAKI T,IEKI Y,et al. Correlation of KAI 1/CD 82 gene expression with good prognosis in patients with non-small cell lung cancer[J]. Cancer Res,1996,56(8) :1751-1755.
  • 9FRIESS H, GUO XZ, BERBERAT P, et al. Reduced KAI 1 expression in pancreatic cancer is associated with lymphnede and distant metastases[J], Int J Cancer, 1998,79(4) :349- 355.
  • 10TTAKAOKA A, HINODA Y, SATOH S, et al. Suppression of invasire properties of colon cancer cells by a metastasis suppressor KAI 1 gene[J]. Oncogene,1998,16( 1 ) :1443- 1453.

二级参考文献7

  • 1马乃绪,孔祥田,邹万忠.前列腺癌的病理诊断[J].诊断病理学杂志,1996,3(1):40-44. 被引量:1
  • 2梁英杰 凌启波.一种快速高敏感的免疫组织化学染色方法-LSAB法[J].中华病理学杂志,1993,22:369-370.
  • 3陈忠年,实用外科病理学,1997年,465页
  • 4Dong J T,Cancer Res,1996年,56卷,4387页
  • 5Guo X Z,Cancer Res,1996年,56卷,4876页
  • 6马乃清,北京医科大学泌尿外科研究所年报,1996年,21页
  • 7梁英杰,中华病理学杂志,1993年,22卷,369页

共引文献4

同被引文献26

  • 1Takechi M. Cadherin cell adhesion receptions as a morphorgenetic regulator[J ]. Science. 1991:251 ( 5000 ) : 1451-5.
  • 2Sommers CL,Thompson EW, Torri JA, et al. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines:relationship to morphology and invasive capacities [ J ]. Cell Gorwth Differ, 1991 ;2 ( 8 ) : 365-72.
  • 3LINDBERG R A, HUNTER T. cDNA cloning and characterization of eck, an epithelial cell receptor protein - tyrosine kinase in the eph/elk family of protein kinases[ J]. Mol Cell Biol, 1990, 10 (12) : 6 316 -6 324.
  • 4VALLADARES A, HERNANDEZ N G, GOMEZ F S, et al, Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women[J]. Cancer Genet Cytogenet, 2006, 170(2) : 147 - 151.
  • 5YAMAGUCHI S, TATSUMI T, TAKEHARA T, et al. Immunotherapy of murine colon cancer using receptor tyrosine kinase E-phA2 - derived peptide - pulsed dendritic cell vaccines[ J]. Cancer, 2007, 110 (7) : 1 469 - 1 477.
  • 6ABRAHAM S, KNAPP D W, CHENG L, et al. Expression of E-phA2 and Ephrin A - 1 in carcinoma of the urinary bladder[J]. Clin Cancer Res, 2006, 12(2): 353-360.
  • 7CHOI K, CREIGHTON C J, STIVERS D, et al. Transcriptional profiling of non - small cell lung cancer cells with activating EGFR somatic mutations[ J]. Plos One, 2007, 2( 11 ): e1 226.
  • 8HESS A R, SEFTOR E A, GRUMAN L M, et al. VE - cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway : implications for vasculogenic mimicry [ J ]. Cancer Biol Ther, 2006, 5(2) : 228 -233.
  • 9WU D, SUO Z, KRISTENSEN G B, et al. Prognostic value of E-phA2 and EphrinA - 1 in squamous cell cervical carcinoma [ J ]. Gynecol Oncol, 2004, 94(2) : 312 -319.
  • 10MEADE-TOLLIN L, MARTINEZ J D. Loss of p53 and overexpression of EphA2 predict poor prognosis for ovarian cancer patients[J]. Cancer Biol Ther, 2007, 6(2) : 288 -289.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部